Cost-Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma.

Passos RMA, Marcolino MAZ, Passos JA, Calsavara VF, de Lourdes Martins Perobelli L, Campolina AG, de Almeida-Neto C

Open source

DOI
10.1002/jca.70026
Published
2025 Jun
Container
Journal of clinical apheresis
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jca.70026,
  title = {Cost-Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma.},
  author = {Passos RMA and Marcolino MAZ and Passos JA and Calsavara VF and de Lourdes Martins Perobelli L and Campolina AG and de Almeida-Neto C},
  year = {2025},
  journal = {Journal of clinical apheresis},
  doi = {10.1002/jca.70026},
  url = {https://doi.org/10.1002/jca.70026}
}

RIS

TY  - JOUR
TI  - Cost-Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma.
AU  - Passos RMA
AU  - Marcolino MAZ
AU  - Passos JA
AU  - Calsavara VF
AU  - de Lourdes Martins Perobelli L
AU  - Campolina AG
AU  - de Almeida-Neto C
PY  - 2025
JO  - Journal of clinical apheresis
DO  - 10.1002/jca.70026
UR  - https://doi.org/10.1002/jca.70026
ER  - 

APA

RMA, P., MAZ, M., JA, P., VF, C., L, D. L. M. P., AG, C., & C, D. A. (2025). Cost-Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma.. Journal of clinical apheresis. https://doi.org/10.1002/jca.70026

Source records